ArticleNoro psikiyatri arsivi2025
The Turkish Short Version of the Sensory Experience Questionnaire: A Validity and Reliability Study in Children with Autism Spectrum Disorder.
Article in Noro psikiyatri arsivi, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The purpose of the present study is to examine the psychometric properties of the Turkish form of the Sensory Experience Questionnaire Short Version (SEQv2.1), which is based on parent or primary caregiver reports, consisting of three sensory response patterns (hyporeactivity, hyperreactivity, and sensory seeking) previously validated in different clinical groups and the general population, on young children with autism spectrum disorder (ASD). Method: The study participants consisted of 180 children with ASD and 65 typically developing children aged between 24 and 80 months. The children's sensory characteristics were measured using the SEQv2.1, which was filled out by their mothers. The study used the Childhood Autism Rating Scale (CARS) to examine concurrent criterion validity and confirm the children's ASD diagnosis. After the SEQv2.1 was translated, the questionnaire's validity was examined with construct and criterion validity, while its reliability was examined with Cronbach's alpha and McDonald's omega internal consistency coefficient. Results: The analyses conducted to examine construct validity showed that the model fit indices for the questionnaire's three-factor structure were acceptable, but not all items had acceptable loading values. Furthermore, the sub-factors of the SEQv2.1 were moderately positively correlated with each other and highly positively correlated with the overall scale, and the mean scores of children with ASD and typically developing children from the sub-factors of the SEQv2.1 and the overall scale significantly differed from each other. The analyses performed for criterion validity demonstrated that the sub-factors of the SEQv2.1 and the overall scale were moderately positively correlated with the CARS. Finally, reliability analyses determined that the sub-factors of the SEQv2.1 were acceptable and the overall scale had a good level of internal consistency reliability. Conclusion: The Turkish form of the SEQv2.1, which includes three sensory response patterns (hyporeactivity, hyperreactivity, and sensory seeking), is generally valid and reliable in determining the sensory characteristics of young children with ASD. However, since not all items have satisfactory loading values, it is thought that inferences regarding the Turkish version of the SEQv2.1 should be made more carefully. Furthermore, since this may be related to the participants' ages, it is recommended that future research be conducted with an older age group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.